業績　聖マリアンナ医科大学脳神経内科学

Kato D, Mitsuhashi S, Miya F, Saitoh S, Okamoto N, Tsunoda T, Kochi Y.
Utility of tissue-specific gene expression scores for gene prioritization in Mendelian diseases.
J Hum Genet, 2022 Dec;67(12)739-742. doi: 10.1038/s10038-022-01071-8.

https://www.nature.com/articles/s10038-022-01071-8

Ueda T, Takaishi S, Yoshie T, Usuki N, Tatsuno K, Ohtsubo H, Araga T, Kaga Y, Takada T.
Long-term outcome and factors associated with restenosis after combination therapy of balloon angioplasty and stenting for symptomatic intracranial stenosis.
BMC Neurol, 2022 Dec;22(1):477

https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-022-03009-1

Komine Y, Shimizu T, Akiyama H, Hagiwara Y, Fukano T, Kuwata C, Hasegawa Y, Yamano Y.

The Usefulness of Heart Rate Variability Spectral Analysis in Detecting Covert Atrial
Fibrillation Among Patients with Cryptogenic Stroke.
St. Marianna Med. J,2022 in press

Kaburagi K, Shimizu T, Hagiwara Y, Fukano T, Shibata S, Hoshino M, Sasaki N, Akiyama H, Hasegawa Y, Yamano Y.

Usefulness of carotid duplex ultrasonography in predicting residual large-vessel occlusions after intravenous recombinant tissue plasminogen activator therapy in patients with acute ischemic stroke.
J Med Ultrason (2001), in press doi: 10.1007/s10396-022-01271-x.

Usefulness of carotid duplex ultrasonography in predicting residual large-vessel occlusions after intravenous recombinant tissue plasminogen activator therapy in patients with acute ischemic stroke (springernature.app)

Shibata S, Sakurai K, Tachikawa K, Ko R, Hino S, Fukano T, Isahaya K, Haraguchi T, Yamauchi J, Tanabe K, Nagasaka M, Hagiwara Y, Shimizu T, Akiyama H, Kobayashi Y, Hasegawa Y, Yamano Y.

The Utility of Automated ASPECTS in Acute Ischemic Stroke for Intravenous Recombinant Tissue Plasminogen Activator (IV-rtPA) Therapy.
Neurol Int, 2022 Dec;14(4):981-990

https://www.mdpi.com/2035-8377/14/4/77

big_cover-neurolint-v14-i4.png (1748×2480) (mdpi.com)

Kikuchi T, Takao N, Sato T, Isahaya K, Hino S, Kaburagi M, Tachikawa K, Ko R, Shibata S, Kaburagi K, Iijima N, Mizukami H, Sakurai K, Yamauchi J, Kimura A, Shimohata T, Yamano Y.

The level of CSF CXCL10 is highly elevated and decreased after steroid therapy in patients with autoimmune glial fibrillary acidic protein astrocytopathy.
Clin. Exp. Neuroimmunol, 2022 Early View

https://onlinelibrary.wiley.com/doi/abs/10.1111/cen3.12732

Matsumoto H, Shiraishi M, Higashi A, Hino S, Kaburagi M, Mizukami H, Maki F, Yamauchi J, Tanabe K, Sato T, Yamano Y.
The Forward and Lateral Tilt Angle of the Neck and Trunk Measured by Three-Dimensional Gait and Motion Analysis as a Candidate for a Severity Index in Patients with Parkinson's Disease.
Neurol Int, 2022;14(3):727-737

https://www.mdpi.com/2035-8377/14/3/61

big_cover-neurolint-v14-i3.png (1748×2480) (mdpi.com)

Nozuma S, Matsuura E, Tashiro Y, Nagata R, Ando M, Hiramatsu Y, Higuchi Y, Sakiyama Y, Hashiguchi A, Michizono K, Higashi K, Matsuzaki T, Kodama D, Tanaka M, Yamano Y, Moritoyo T, Kubota R, Takashima H.
Efficacy of l-Arginine Treatment in Patients with HTLV-1-Associated Neurological Disease.
Ann Clin Transl Neurol, in press

Puccioni-Sohler M, Poton AD, Cabral-Castro MJ, Yamano Y, Taylor G, Casseb J.
Human T lymphotropic virus type 1-associated myelopathy: overview of HTLV-1/2 tests and potential biomarkers.
AIDS Res Hum Retroviruses, 2022 Dec;38(12):924-932. doi: 10.1089/AID.2022.0028.

https://pubmed.ncbi.nlm.nih.gov/35819286/

Ueda T, Hasegawa Y, Takeuchi M, Morimoto M, Tsuboi Y, Yamamoto R, Kaku S, Ayabe J, AkiyamaT, Ishima D, Mori K, Kagami H, Ito H, Onodera H, Doi H, Tsumoto T, Hataoka S, Noda M, Tomura N, Masuo O, Yoshida Y, Kaga Y, Tatsuno K, Yoshie T, Takaishi S, Yamano Y.
Primary results of mechanical thrombectomy for acute ischemic stroke: The K-NET registry in the Japanese metropolitan area.
International Journal of Stroke,, 2022 Nov. DOI: 10.1177/17474930221138014

Sasaki N, Sato T, Yamatoku M, Yamano Y.
Efficacy of repetitive transcranial magnetic stimulation for gait disturbance in HTLV-1 associated myelopathy.
NeuroRehabilitation, 2022 51(3):519-526. doi: 10.3233/NRE-220105.

Tanaka Y, Sato T, Yagishita N, Yamauchi J, Araya N, Aratani S, Takahashi K, Kunitomo Y, Nagasaka M, Kanda Y, Uchimaru K, Morio T, Yamano Y.
Potential Role of HTLV-1 Tax-Specific Cytotoxic T Lymphocytes expressing a Unique T-cell Receptor to Promote Inflammation of the Central Nervous System in Myelopathy Associated with HTLV-1.
Front. Immunol, 2022 Aug;13:993025. doi: 10.3389/fimmu.2022.993025.

Yoshie T, Matsuda Y, Arakawa Y, Otsubo H, Araga T, Tatsuno K, Takaishi S, Usuki N, Ueda T.
The Influence of Experience on Gazing Patterns during Endovascular Treatment: Eye-Tracking Study.
Journal of Neuroendovascular Therapy, 2022 Jun;16(6):294-300

Hagiwara Y, Takao N, Usuki N, Yoshie T, Takaishi S, Shimizu T, Ueda T, Hasegawa Y, Yamano Y.
Carotid ultrasound using superb microvascular imaging to identify patients developing in-stent restenosis after CAS.
J Stroke Cerebrovasc Dis, 2022 Jul;31(8):106627. doi:10.1016/j.jstrokecerebrovasdis.2022.106627.

https://pubmed.ncbi.nlm.nih.gov/35797762/

Shimizu T, Ueno Y, Takeishi Y, Doijiri R, Kuriki A, Kikuno M, Takekawa H, Shimada Y, Kanemaru K, Kamiya Y, Yamaguchi E, Koga M, Ihara M, Tsujino A, Hirata K, Hasegawa Y, Hattori N, Urabe T.
Evaluating the Potential Pathology and Short-Term Outcomes of Cryptogenic Stroke Using the Etiological Classification System. doi: 10.5551/jat.63267.
J Atheroscler Thromb, 2022 in press

https://pubmed.ncbi.nlm.nih.gov/35691846/

Wada Y, Sato T, Hasegawa H, Matsudaira T, Nao N, Coler-Reilly ALG, Tasaka T, Yamauchi S, Okagawa T, Momose H, Tanio M, Kuramitsu M, Sasaki D, Matsumoto N, Yagishita N, Yamauchi J, Araya N, Tanabe K, Yamagishi M, Nakashima M, Nakahata S, Iha H, Ogata M, Muramatsu M, Imaizumi Y, Uchimaru K, Miyazaki Y, Konnai S, Yanagihara K, Morishita K, Watanabe T, Yamano Y, Saito M.
RAISING is a high-performance method for identifying random transgene integration sites.
Commun Biol, 2022 Jun;5(1):535 doi: 10.1038/s42003-022-03467-w.

https://www.nature.com/articles/s42003-022-03467-w.pdf

Imai T, Shinohara K, Uchino K, Okuma H, Maki F, Hiruma K, Ariizumi Y, Yamano Y.
Paraneoplastic cerebellar degeneration with anti-Yo antibodies and an associated submandibular gland tumor: a case report.
BMC Neurol., 2022 May;22(1):165. doi: 10.1186/s12883-022-02684-4.

https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-022-02684-4

Kamoi K, Watanabe T, Uchimaru K, Okayama A, Seiko K, Kawamata T, Kurozumi-Karube H, Horiguchi N, Zong Yuan, Yamano Y, Hamaguchi I, Nannya Y, Tojo A, and Ohno-Matsui K. Updates on HTLV-1 Uveitis.
Viruses, 2022 Apr;14(4)794 doi:10.3390/v14040794

https://www.mdpi.com/1999-4915/14/4/794

Kimura M, Yamauchi J, Sato T, Yagishita N, Araya N, Aratani S, Tanabe K, Horibe E, Watanabe T, Coler-Reilly ALG, Nagasaka M, Akasu Y, Kaburagi K, Kikuchi T, Shibata S, Matsumoto H, Koseki A, Inoue S, Takata A, Yamano Y.
Health-related quality of life evaluation using the Short Form-36 in patients with human T-lymphotropic virus type 1-associated myelopathy.
Front Med(Lausanne), 2022 Apr;9:879379. doi: 10.3389/fmed.2022.879379.

https://www.frontiersin.org/articles/10.3389/fmed.2022.879379/full?&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&field=&journalName=Frontiers_in_Medicine&id=879379

Uchida M, Ito H, Takasuna H, Goto T, Takumi I, Fukano T, Hagiwara Y, Tanaka Y.
Initial experience with left transradial neurointerventions for cerebral aneurysms using the 6-French Simmons guiding sheath.
J Stroke Cerebrovasc Dis, 2022 Apr;31(4):106350.
doi: 10.1016/j.jstrokecerebrovasdis.2022.106350.

https://reader.elsevier.com/reader/sd/pii/S1052305722000477?token=E122BD3538E8EC5A35904EAF9C21A40EFFD4258A909075BAEB364170FE7831E633B0AB39F6014C244E1CE2A36A044C85&originRegion=us-east-1&originCreation=20220711054705

Takeda H, Imoto K, Umemoto K, Doi A, Arai H, Horie Y, Mizukami T, Oguri T, Ogura T, Izawa N,
Yamamoto H, Yamano Y, Sunakawa Y.
Clinical Utility of Genomic Profiling Tests in Patients with Advanced Gastrointestinal Cancers.
Target Oncol, 2022 Mar;17(2):177-185.

https://link.springer.com/article/10.1007/s11523-022-00871-4

Nakajima T, Yoshifuji H, Yamano Y, Yurugi K, Miura Y, Maekawa T, Yoshida T, Handa H, Ohmura K, Mimori T, Terao C.
Co-occurrence of Relapsing Polychondritis and Autoimmune Thyroid Diseases.
Orphanet J Rare Dis, 2022 May;17(1):101 doi:10.1186/s13023-022-02261-5.　

https://ojrd.biomedcentral.com/articles/10.1186/s13023-022-02261-5

Tsujikawa K, Hamanaka K, Riku Y, Hattori Y, Hara N, Iguchi Y, Ishigaki S, Hashizume A, Miyatake S, Mitsuhashi S, Miyazaki Y, Kataoka M, Jiayi L, Yasui K, Kuru S, Koike H, Kobayashi K, Sahara N, Ozaki N, Yoshida M, Kakita A, Saito Y, Iwasaki Y, Miyashita A, Iwatsubo T; Japanese Alzheimer’s
Disease Neuroimaging Initiative (J-ADNI); Ikeuchi T; Japanese Longitudinal Biomarker Study in PSP and CBD (JALPAC) Consortium; Miyata T, Sobue G, Matsumoto N, Sahashi K, Katsuno M.
Actin-binding protein filamin-A drives tau aggregation andcontributes to progressive
supranuclear palsy pathology.
Sci Adv, 2022 May:8(21):eabm5029. doi: 10.1126/sciadv.abm5029.　

https://www.science.org/doi/pdf/10.1126/sciadv.abm5029

Hamanaka K, Miyake N, Mizuguchi T, Miyatake S, Uchiyama Y, Tsuchida N, Sekiguchi F, Mitsuhashi S, Tsurusaki Y, Nakashima M, Saitsu H, Yamada K, Sakamoto M, Fukuda H, Ohori S, Saida K, Itai T, Azuma Y, Koshimizu E, Fujita A, Erturk B, Hiraki Y, Ch'ng GS, Kato M, Okamoto N, Takata A, Matsumoto N.
Large- scale discovery of novel neurodevelopmental disorder-related genes through a unified analysis of single-nucleotide and copy number variants.
Genome Med, 2022 Apr;14(1):40. doi: 10.1186/s13073-022-01042-w.　

https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-022-01042-w

Hoshino M, Sasaki R, Tsuchihashi Y, Otsuka Y, Sakurai K, Yamano Y.
A case of autoimmune encephalitis with involuntary movements as the first symptom and suspected association with mumps virus infection
Rinsho Shinkeigaku,　2022;62(2):140-144 doi:10.5692/clinicalneurol.cn-001669.

Mikami K, Shiraishi M, Kamo T.
Effect of subjective vertical perception on lateral flexion posture of patients with Parkinson's disease.
Sci Rep,, 2022 Jan;12(1):1532 doi: 10.1038/s41598-022-05587-z.

https://www.nature.com/articles/s41598-022-05587-z.pdf

Okada Y, Shiraishi M, Hori K, Yamaguchi K, Hasegawa Y.
Relationship between cerebral blood flow reduction patterns on scintigraphy and nonmotor symptoms in new-onset lewy body disease.
Nucl Med Rev,, 2022; 25(1)18-24 doi: 10.5603/NMR.a2022.0005.

https://journals.viamedica.pl/nuclear_medicine_review/article/view/84414

Yamauchi J, Tanabe K, Sato T, Nakagawa M, Matsuura E, Tsuboi Y, Tamaki K, Sakima H, Ishihara S, Ohta Y, Matsumoto N, Kono K, Yagishita N, Araya N, Takahashi K, Kunitomo Y, Nagasaka M, Coler-Reilly ALG, Hasegawa Y, Araujo A, Jacobson S, Grassi MFR, Galvão-Castro B, Bland M, Taylor GP, Martin F, Yamano Y.
Efficacy of corticosteroid therapy for HTLV-1-associated myelopathy/tropical spastic paraparesis: A randomized controlled trial (HAMLET-P).
Viruses, 2022 Jan;14(1):136

https://doi.org/10.3390/v14010136

Takao N, Yamano Y.
Forefront studies on HTLV-1-associated myelopathy/tropical spasti cparaparesis (HAM/TSP).
Clin Exp Neuroimmunol, 2022 Jan;13（1）：34-41．doi: org/10.1111/cen3.12687.

https://onlinelibrary.wiley.com/doi/10.1111/cen3.12687

Shimizu J, Yamano Y, Kawahara K, Suzuki N.
Nationwide cross-sectional survey of patients with relapsing polychondritis in 2019
demonstrates reduction of airway involvement compared with that in 2009.
Sci Rep, 2022 Jan;12(1):465. doi: 10.1038/s41598-021-04493-0

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748451/pdf/41598_2021_Article_4493.pdf